1987
DOI: 10.1038/jid.1987.8
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Atherogenic Risk of Isotretinoin-induced and Etretinate-induced Alterations of Lipoprotein Cholesterol Metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1989
1989
2011
2011

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Isotretinoin at pharmacological doses elevates plasma triglycerides and induces overt hypertriglyceridemia. [184][185][186] There are at least three mechanisms involved in the generation of isotretinoininduced hypertriglyceridema:…”
Section: Isotretinoin-induced Hypertriglyceridemiamentioning
confidence: 99%
“…Isotretinoin at pharmacological doses elevates plasma triglycerides and induces overt hypertriglyceridemia. [184][185][186] There are at least three mechanisms involved in the generation of isotretinoininduced hypertriglyceridema:…”
Section: Isotretinoin-induced Hypertriglyceridemiamentioning
confidence: 99%
“…Retinoids at pharmacological doses increase plasma triglycerides and induce overt hypertriglyceridemia in more than 20% of the patients [104–106]. Hepatic very low density lipoprotein (VLDL) production is facilitated by microsomal triglyceride transfer protein (MTP) in a rate‐limiting step that is regulated by insulin.…”
Section: Foxo1 and The Therapeutic Effect Of Retinoidsmentioning
confidence: 99%